These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 6809158)

  • 21. Stability of freeze-dried and reconstituted measles vaccines.
    Peetermans J; Colinet G; Stephenne J; Bouillet A
    Dev Biol Stand; 1978; 41():259-64. PubMed ID: 753654
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical trial of live measles vaccine given alone and live vaccine preceded by killed vaccine. Fourth report to the medical research council by the measles sub-committee of the committee on development of vaccines and immunisation procedures.
    Lancet; 1977 Sep; 2(8038):571-5. PubMed ID: 71396
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunogenicity of measles and rubella vaccines in Oman: a prospective clinical trial.
    Kohler KA; Suleiman AJ; Robertson SE; Malankar P; Al-Khusaiby S; Helfand RF; Brown D; Bellini WJ; Sutter RW
    J Infect Dis; 2003 May; 187 Suppl 1():S177-85. PubMed ID: 12721911
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Seroconversion after measles vaccination in infants and children.
    Seghal S; Sharma RS; Das A; Sebastian M; Arora RR
    J Commun Dis; 1983 Jun; 15(2):75-9. PubMed ID: 6630988
    [No Abstract]   [Full Text] [Related]  

  • 25. [Measurement of the in vitro immune response of live attenuated measles virus vaccine and antibody levels in 0 to 10-year-old children].
    Unalan H; Ustaçelebi S
    Mikrobiyol Bul; 1985 Oct; 19(4):218-28. PubMed ID: 3831724
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exposure to heat and freezing in the vaccine cold chain in Thailand.
    Techathawat S; Varinsathien P; Rasdjarmrearnsook A; Tharmaphornpilas P
    Vaccine; 2007 Jan; 25(7):1328-33. PubMed ID: 17157419
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Simultaneous administration of live attenuated measles vaccine with DTP vaccine.
    McBean AM; Gateff C; Manclark CR; Foster SO
    Pediatrics; 1978 Sep; 62(3):288-93. PubMed ID: 704197
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Measles vaccination: study of humoral immunity in children vaccinated in the Tunis region].
    Arrouji A; Mirchamsy H; Marnissi A
    Arch Inst Pasteur Tunis; 1982 Mar; 59(1):173-80. PubMed ID: 7181563
    [No Abstract]   [Full Text] [Related]  

  • 29. Measles vaccination of macaques by dry powder inhalation.
    de Swart RL; LiCalsi C; Quirk AV; van Amerongen G; Nodelman V; Alcock R; Yüksel S; Ward GH; Hardy JG; Vos H; Witham CL; Grainger CI; Kuiken T; Greenspan BJ; Gard TG; Osterhaus AD
    Vaccine; 2007 Jan; 25(7):1183-90. PubMed ID: 17084489
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The development and duration of immunity in children vaccinated against measles with the Edmonston-Zagreb vaccine].
    Borcić B; Smerdel S; Abu Eldan J; Kolić J; Ferdebar M; Kordić D; Mohacek N
    Lijec Vjesn; 1989; 111(4-5):131-4. PubMed ID: 2770398
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Simultaneous administration of smallpox, measles, yellow fever, and diphtheria-pertussis-tetanus antigens to Nigerian children.
    Ruben FL; Smith EA; Foster SO; Casey HL; Pifer JM; Wallace RB; Atta AI; Jones WL; Arnold RB; Teller BE; Shaikh ZQ; Lourie B; Eddins DL; Doko SM; Foege WH
    Bull World Health Organ; 1973; 48(2):175-81. PubMed ID: 4541683
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Seroconversion following measles immunisation.
    Swami SS; Chandra S; Dudani IU
    J Commun Dis; 1987 Jun; 19(2):141-5. PubMed ID: 3454353
    [No Abstract]   [Full Text] [Related]  

  • 33. Antibody response and clinical reactions in children given measles vaccine with immunoglobulin.
    Lingam S; Miller CL; Clarke M; Pateman J
    Br Med J (Clin Res Ed); 1986 Apr; 292(6527):1044-5. PubMed ID: 3083994
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potency status and efficacy of measles vaccine administered in Nigeria: a case study of three EPI centres in Lagos, Nigeria.
    Omilabu SA; Oyefolu AO; Ojo OO; Audu RA
    Afr J Med Med Sci; 1999; 28(3-4):209-12. PubMed ID: 11205835
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Five cases of measles secondary vaccine failure with confirmed seroconversion after live measles vaccination.
    Hirose M; Hidaka Y; Miyazaki C; Ueda K; Yoshikawa H
    Scand J Infect Dis; 1997; 29(2):187-90. PubMed ID: 9181657
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The combination measles, mumps, rubella and varicella vaccine in healthy children.
    Arbeter AM; Baker L; Starr SE; Plotkin SA
    Dev Biol Stand; 1986; 65():89-93. PubMed ID: 3030864
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Comparative evaluation of 3 measles vaccines. 3. Evaluation of the hemagglutination inhibition test for assaying measles antibodies after vaccination].
    Polna I; Naruszewicz-Lesiuk D; Pilecka T
    Przegl Epidemiol; 1970; 24(3):339-47. PubMed ID: 5482214
    [No Abstract]   [Full Text] [Related]  

  • 38. CHRONOVAC VOYAGEUR: A study of the immune response to yellow fever vaccine among infants previously immunized against measles.
    Goujon C; Gougeon ML; Tondeur L; Poirier B; Seffer V; Desprès P; Consigny PH; Vray M;
    Vaccine; 2017 Oct; 35(45):6166-6171. PubMed ID: 28958813
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Measles vaccine failure. A survey of causes and means of prevention.
    Hayden GF
    Clin Pediatr (Phila); 1979 Mar; 18(3):155-6, 161-3, 167. PubMed ID: 371890
    [No Abstract]   [Full Text] [Related]  

  • 40. Comparative efficacy of three measles vaccines in Indian children.
    Banerjee K; Shaikh N; Phadke M; Bedekar SS; Rauta SK; Mehta JM
    Indian J Public Health; 1998; 42(4):113-9. PubMed ID: 10389523
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.